Actively Recruiting
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
Led by Mayo Clinic · Updated on 2026-03-13
4500
Participants Needed
2
Research Sites
252 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
CONDITIONS
Official Title
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients, ages 18 to 100 years
- Had a benign breast biopsy at Mayo Clinic between 2002-2022
You will not qualify if you...
- All male patients
- Prior or concomitant diagnosis of breast cancer
- Diagnosis of breast cancer within six months of benign breast disease
- Denial of research authorization
- Concurrent or post-biopsy bilateral prophylactic mastectomy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980
Actively Recruiting
2
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
L
Laura Pacheco-Spann
CONTACT
C
Clinical Trials Referral Office
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here